Drug: Trastuzumab Injury: Cardiac failure Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
92726612 | Trastuzumab | Cardiac failure | BAXTER | 42.95 YR | F | 98 KG | 20160913 | AT |
109598247 | Trastuzumab | Cardiac failure | ROCHE | 0.00 | F | 76 KG | 20160712 | DE |
117774494 | TRASTUZUMAB | Cardiac failure | AVENTIS | 85.00 YR | F | 0 | 20160921 | ES |
119654222 | Trastuzumab | Cardiac failure | ROCHE | 0.00 | 0 | 20160901 | FR | |
120104318 | Trastuzumab | Cardiac failure | ROCHE | 86.40 YR | F | 86 KG | 20160908 | BE |
125398661 | TRASTUZUMAB | Cardiac failure | NOVARTIS | 61.99 YR | F | 61 KG | 20160708 | FR |
125875171 | Trastuzumab | Cardiac failure | ROCHE | 59.34 YR | F | 58 KG | 20160725 | DE |
126467431 | Trastuzumab | Cardiac failure | ROCHE | 0.00 | F | 0 | 20160812 | GB |
Total Records: 8 Number of Pages: 1